Senin, 28 November 2011

Common Vesiculobullous Diseases Etiology,Clinical Presentation,Microscopic findings,Diagnosis,Differential diagnosis and Treatment

Epidermolysis Bullosa

Etiology
• A diverse group of predominantly cutaneous, but also mucosal, mechanobullous diseases
• Inherited form: autosomal dominant or recessive patterns may occur
• Acquired form (acquisita): autoimmune from autoantibodies (immunoglobulin G [IgG]) to type VII collagen deposited within the basement membrane zone and upper dermis or lamina propria

Clinical Presentation
• Variable, depending upon the specific form of many subtypes recognized
• Mucosal lesions range in severity from mild to debilitating, depending on subtype:
• Inherited forms have wide range of oral mucosal involvement, with most severe form (autosomal recessive, dermolytic) also demonstrating enamel hypoplasia and caries
• Acquisita form with mucous membrane pemphigoid variant shows oral and conjunctival erosions/blisters
• Mucosal involvement absent in several variants
• Scarring and stricture formation common in severe recessive forms
• Mucosa is often friable, but it may be severely blistered, eroded, or ulcerated.
• Loss of oral anatomic landmarks may follow severe scarring (eg, tongue mucosa may become smooth and atrophic with episodes of blistering and scarring).
• Obliteration of vestibules, reduction of oral opening, ankyloglossia
• Scarring can be associated with atrophy and leukoplakia, with increased risk for squamous cell carcinoma development.

Microscopic Findings
• Bullae vary in location depending upon the form that is present:
• Intraepithelial in nonscarring forms
• At epithelial–connective tissue junction in dystrophic forms
• Subepithelial/intradermal in scarring forms
• Ultrastructural findings are as follows:
• Intraepithelial forms associated with defective cytokeratin groups
• Junctional forms associated with defective anchoring filaments at hemidesmosomal sites (epithelial–connective tissue junction)
• Dermal types demonstrate anchoring fibril or collagen destruction.

Diagnosis
• Distribution of lesions
• Family history
• Microscopic evaluation
• Ultrastructural evaluation
• Immunohistochemical evaluation of basement membrane zone using specific labeled antibodies as markers for site of blister formation

Differential Diagnosis
• Varies with specific form
• Generally includes the following:
• Bullous pemphigoid
• Mucous membrane (cicatricial) pemphigoid
• Erosive lichen planus
• Dermatitis herpetiformis
• Porphyria cutanea tarda
• Erythema multiforme
• Bullous impetigo
• Kindler syndrome
• Ritter’s disease

Treatment
• Acquisita form:
• Some recent success with colchicine and dapsone
• Immunosuppressive agents including azathioprine, methotrexate, and cyclosporine may be effective
• Acquisita and inherited forms:
• Avoidance of trauma
• Dental prevention strategies including extra-soft brushes, daily topical fluoride applications, dietary counseling

Prognosis
• Widely variable depending on subtype




Erythema Multiforme

Etiology
• Many cases preceded by infection with herpes simplex; less often with Mycoplasma pneumoniae or other organisms
• May be related to drug consumption, including sulfonamides, other antibiotics, analgesics, phenolphthalein-containing laxatives, barbiturates
• Another trigger may be radiation therapy.
• Essentially an immunologically mediated reactive process, possibly related to circulating immune complexes

Clinical Presentation
• Acute onset of multiple, painful, shallow ulcers and erosions with irregular margins
• Early mucosal lesions are macular, erythematous, and occasionally bullous.
• May affect oral mucosa and skin synchronously or metachronously
• Lips most commonly affected with eroded, crusted, and hemorrhagic lesions (serosanguinous exudate) known as Stevens-Johnson syndrome when severe
• Predilection for young adults
• As many as one-half of oral cases have associated erythematous to bullous skin lesions.
• Target or iris skin lesions may be noted over extremities.
• Genital and ocular lesions may occur.
• Usually self-limiting; 2- to 4-week course
• Recurrence is common.

Diagnosis
• Appearance
• Rapid onset
• Multiple site involvement in one-half of cases
• Biopsy results often helpful, but not always diagnostic

Differential Diagnosis
• Viral infection, in particular, acute herpetic gingivostomatitis (Note: Erythema multiforme rarely affects the gingiva.)
• Pemphigus vulgaris
• Major aphthous ulcers
• Erosive lichen planus
• Mucous membrane (cicatricial) pemphigoid

Treatment
• Mild (minor) form: symptomatic/supportive treatment with adequate hydration, liquid diet, analgesics, topical corticosteroid agents
• Severe (major) form: systemic corticosteroids, parenteral fluid replacement, antipyretics
• If evidence of an antecedent viral infection or trigger exists, systemic antiviral drugs during the disease or as a prophylactic measure may help.
• See “Therapeutics” section for details.

Prognosis
• Generally excellent
• Recurrences common

 

Hand-Foot-and-Mouth Disease

Etiology
• A very common enterovirus infection (coxsackievirus A10 or A16), which may occur in mild epidemic proportion, chiefly in children
• Incubation period is short, usually less than 1 week

Clinical Presentation
• Oral mucosal lesions with focal herpes simplex–like appearance, usually involving nonkeratinized tissue (soft palate, floor of mouth, labial-buccal mucosa)
• Accompanying palmar, plantar, and digital lesions are deeply seated, vesicular, and erythematous
• Short course with mild symptoms

Diagnosis
• Concomitant oral and cutaneous lesions
• Skin lesions commonly involve hands and feet.
• Skin lesions may involve buttocks.
• Antibody-titer increase measured between acute and recovery phases

Differential Diagnosis
• Herpangina
• Herpes simplex infection
• Acute lymphonodular pharyngitis

Treatment
• Symptomatic treatment only
• Patient should be cautioned against the use of aspirin to manage fever.

Prognosis
• Excellent
• Lifelong immunity, but it is strain specific



Herpangina

Etiology
• Most often by members of coxsackievirus group A (7, 9, 10, and 16) or group B (1–5)
• Occasionally due to echovirus 9 or 17

Clinical Presentation
• Incubation period of 5 to 9 days
• Acute onset
• Usually endemic in young children; usually occurs in summer
• Often subclinical
• Posterior oral cavity, tonsillar pillars involved
• Macular erythematous areas precede short-lived vesicular eruption, followed by superficial ulceration
• Accompanied by pharyngitis, dysphagia, fever, malaise, headache, lymphadenitis, and vomiting
• Self-limiting course, usually under 2 weeks

Diagnosis
• Other viral illnesses to be ruled out or separated
• Course, time of year, location of lesions, contact with known infected individual

Differential Diagnosis
• Hand-foot-and-mouth disease
• Varicella
• Acute herpetic gingivostomatitis

Treatment
• Soft diet
• Hydration
• Antipyretics
• Chlorhexidine rinses
• Compounded mouth rinses

Prognosis
• Excellent


Herpetic Stomatitis: Primary

Etiology
• Herpes simplex virus (HSV)
• Over 95% of oral primary herpes due to HSV-1
• Physical contact is mode of transmission

Clinical Presentation
• 88% of population experience subclinical infection or mild transient symptoms
• Most cases occur in those between 0.5 and 5 years of age.
• Incubation period of up to 2 weeks
• Abrupt onset in those with low or absent antibody to HSV-1
• Fever, anorexia, lymphadenopathy, headache, in addition to oral ulcers
• Coalescing, grouped, pinhead-sized vesicles that ulcerate
• Ulcers show a yellow, fibrinous base with an erythematous halo
• Both keratinized and nonkeratinized mucosa affected
• Gingival tissue with edema, intense erythema, pain, and tenderness
• Lips, perioral skin may be involved
• 7- to 14-day course

Diagnosis
• Usually by clinical presentation and pattern of involvement
• Cytology preparation to demonstrate multinucleate virusinfected giant epithelial cells
• Biopsy results of intact macular area show intraepithelial vesicles or early virus-induced epithelial (cytopathic) changes
• Viral culture or polymerase chain reaction (PCR) examination of blister fluid or scraping from base of erosion

Differential Diagnosis
• Herpangina
• Hand-foot-and-mouth disease
• Varicella
• Herpes zoster (shingles)
• Erythema multiforme (typically no gingival lesions)

Treatment
• Soft diet and hydration
• Antipyretics (avoid aspirin)
• Chlorhexidine rinses
• Systemic antiviral agents (acyclovir, valacyclovir) if early in course or in immunocompromised patients
• Compounded mouth rinse

Prognosis
• Excellent in immunocompetent host
• Remission/latent phase in nearly all those affected who have adequate antibody titers


Impetigo

Etiology
• Cutaneous bacterial infection: Streptococcus and Staphylococcus species
• Is spread through direct contact
• Highly contagious

Clinical Presentation
• Honey-colored, perioral crusts preceded by vesicles
• Flaccid bullae less common (bullous impetigo)

Diagnosis
• Clinical features
• Culture of organism (usually group A, â-hemolytic streptococci or group II Staphylococcus aureus)
• Herpes simplex (recurrent)
• Exfoliative cheilitis
• Drug eruptions
• Other vesiculobullous diseases

Treatment
• Topical antibiotics (mupirocin, clindamycin)
• Systemic antibiotics

Prognosis
• Excellent
• Rarely, poststreptococcal glomerulonephritis may develop.


Mucous Membrane Pemphigoid

Etiology
• Autoimmune; trigger unknown
• Autoantibodies directed against basement membrane zone antigens

Clinical Presentation
• Vesicles and bullae (short lived) followed by ulceration
• Multiple intraoral sites (occasionally gingiva only)
• Usually in older adults
• 2:1 female predilection
• Ocular lesions noted in one-third of cases
• Proclivity for scarring in ocular, laryngeal, nasopharyngeal, and oropharyngeal tissues

Microscopic Findings        
• Subepithelial cleft formation
• Linear pattern IgG and complement 3 (C3) along basement membrane zone; less commonly IgA
• Direct immunofluorescence examination positive in 80% of cases
• Indirect immunofluorescence examination usually negative
• Immunoreactants deposited in lamina lucida in most patients

Diagnosis
• Biopsy
• Direct immunofluorescent examination

Differential Diagnosis
• Pemphigus vulgaris
• Erythema multiforme
• Erosive lichen planus
• Lupus erythematosus
• Epidermolysis bullosa acquisita

Treatment
• Topical corticosteroids
• Systemic prednisone, azathioprine, or cyclophosphamide
• Tetracycline/niacinamide
• Dapsone
• See “Therapeutics” section for details.

Prognosis
• Morbidity related to mucosal scarring (oropharyngeal, nasopharyngeal, laryngeal, ocular, genital)
• Management often difficult due to variable response to corticosteroids
• Management often requires multiple specialists working in concert (dental, dermatology, ophthalmology, otolaryngology)





Paraneoplastic Pemphigus

Etiology
• Autoimmune, triggered by malignant or benign tumors
• Autoantibodies directed against a variety of epidermal antigens including desmogleins 3 and 1, desmoplakins I and II, and other desmosomal antigens, as well as basement membrane zone antigens

Clinical Presentation
• Short-lived vesicles and bullae followed by erosion and ulceration; resembles oral pemphigus
• Multiple oral sites
• Severe hemorrhagic, crusted erosive cheilitis
• Painful lesions
• Cutaneous lesions are polymorphous; may resemble lichen planus, erythema multiforme, or bullous pemphigoid
• Underlying neoplasms such as non-Hodgkin’s lymphoma, leukemia, thymoma, spindle cell neoplasms, Waldenström’s macroglobulinemia, and Castleman’s disease

Microscopic Findings
• Suprabasilar acantholysis, keratinocyte necrosis, and vacuolar interface inflammation
• Direct immunofluorescent testing is positive for epithelial cell surface deposition of IgG and C3 and a lichenoid tissue reaction interface deposition pattern
• Indirect immunofluorescent testing is positive for epithelial cell surface IgG antibodies
• Special testing with mouse and rat bladder, cardiac muscle, and liver may demonstrate paraneoplastic pemphigus antibodies that bind to simple columnar and transitional epithelia

Diagnosis
• Biopsy of skin or mucosa
• Direct immunofluorescent examination of skin or mucosa
• Indirect immunofluorescent examination of sera including special substrates

Differential Diagnosis
• Pemphigus vulgaris
• Erythema multiforme
• Stevens-Johnson syndrome
• Mucous membrane (cicatricial) pemphigoid
• Erosive oral lichen planus

Treatment
• Identification of concurrent malignancy
• Immunosuppressive therapy

Prognosis
• Good with excision of benign neoplasms
• Grave, usually fatal, with malignancies
• Management is very challenging.




Pemphigus Vulgaris

Etiology
• An autoimmune disease where antibodies are directed toward the desmosome-related proteins desmoglein 3 or desmoglein 1
• A drug-induced form exists with less specificity in terms of immunologic features, clinical presentation, and histopathology

Clinical Presentation
• Over 50% of cases develop oral lesions as the initial manifestation
• Oral lesions develop in 70% of cases
• Painful, shallow irregular ulcers with friable adjacent mucosa
• Nonkeratinized sites (buccal, floor, ventral tongue) often are initial sites affected
• Lateral shearing force on uninvolved skin or mucosa can produce a surface slough or induce vesicle formation (Nikolsky sign)

Microscopic Findings
• Separation or clefting of suprabasal from basal layer of epithelium
• Intact basal layer of surface epithelium
• Vesicle forms at site of epithelial split
• Nonadherent spinous cells float in blister fluid (Tzanck cells)
• Direct immunofluorescence examination positive in all cases
• IgG localization to intercellular spaces of epithelium
• C3 localization to intercellular spaces in 80% of cases
• IgA localization to intercellular spaces in 30% of cases
• Indirect immunofluorescence examination positive in 80% of cases
• General correlation with severity of clinical disease

Diagnosis
• Clinical appearance
• Mucosal manifestations
• Direct/indirect immunofluorescent studies

Differential Diagnosis
• Mucous membrane (cicatricial) pemphigoid
• Erythema multiforme
• Erosive lichen planus
• Drug reaction
• Paraneoplastic pemphigus

Treatment
• Systemic immunosuppression
• Prednisone, azathioprine, mycophenolate mofetil, cyclophosphamide
• Plasmapheresis plus immunosuppression
• IVIg for some recalcitrant cases
• See “Therapeutics” section for details.

Prognosis
• Guarded
• Approximately a 5% mortality rate secondary to long-term systemic corticosteroid–related complications





Recurrent Herpetic Stomatitis: Secondary

Etiology
• Herpes simplex virus
• Reactivation of latent virus

Clinical Presentation
• Prodrome of tingling, burning, or pain at site of recurrence
• Multiple, grouped, fragile vesicles that ulcerate and coalesce
• Most common on vermilion border of lips or adjacent skin
• Intraoral recurrences characteristically on hard palate or attached gingiva (masticatory mucosa)
• In immunocompromised patients, lesions may occur in any oral site and are more severe (herpetic geometric glossitis).

Diagnosis
• Characteristic clinical presentation and history
• Viral culture or PCR examination of blister fluid or scraping from base of erosion
• Cytologic smear
• Direct immunofluorescence examination of smear

Differential Diagnosis
• Erythema multiforme
• Herpes zoster (shingles)
• Herpangina
• Hand-foot-and-mouth disease

Treatment
• Acyclovir or valacyclovir early in prodrome
• Supportive
• Acyclovir may be used for prophylaxis for seropositive transplant patients
• Ganciclovir may be used for human immunodeficiency virus (HIV)-positive patients, especially those co-infected with cytomegalovirus.
• For recurrent herpes labialis, see “Therapeutics” section.

Prognosis
• Excellent
• Healing without scarring within 10 to 14 days
• Protracted healing in HIV-positive patients




Stevens-Johnson Syndrome

Etiology
 • A complex mucocutaneous disease affecting two or more mucosal sites simultaneously
• Most common trigger: antecedent recurrent herpes simplex infection
• Infection with Mycoplasma also may serve as a trigger.
• Medications may serve as initiators in some cases.
• Sometimes referred to as “erythema multiforme major”

Clinical Presentation
• Labial vermilion and anterior portion of oral cavity usually affected initially
• Early phase is macular followed by erosion, sloughing, and painful ulceration
• Lip ulcers appear crusted and hemorrhagic.
• Pseudomembrane; foul-smelling presentation as bacterial colonization supervenes
• Posterior oral cavity and oropharyngeal involvement leads to odynophagia, sialorrhea, drooling
• Eye (conjunctival) involvement may occur.
• Genital involvement may occur.
• Cutaneous involvement may become bullous.
• Iris or target lesions are characteristic on skin.

Microscopic Findings
• Subepithelial separation with basal cell liquefaction
• Intraepithelial neutrophils
• Epithelial and connective tissue edema
• Perivascular lymphocytic infiltrate

Diagnosis
• Usually made on clinical grounds
• Histopathology is not diagnostic.

Differential Diagnosis
• Pemphigus vulgaris
• Paraneoplastic pemphigus
• Mucous membrane (cicatricial) pemphigoid
• Bullous pemphigoid
• Acute herpetic gingivostomatitis
• Stomatitis medicamentosa

Treatment
• Hydration and local symptomatic measures
• Topical compounded oral rinses
• Systemic corticosteroid use controversial
• Recurrent, virally associated cases may be reduced in frequency with use of daily, low-dose antiviral prophylactic therapy (acyclovir, famciclovir, valacyclovir).
• May require admission to hospital burn unit

Prognosis
• Good; self-limiting usually
• Recurrences not uncommon





Varicella and Herpes Zoster

Etiology
• Primary and recurrent forms due to varicella-zoster virus (VZV)
• Primary VZV (chickenpox): a childhood exanthem
• Secondary (recurrent) VZV (herpes zoster/shingles) infection: most common in elderly or immunocompromised adults

Clinical Presentation
• Varicella (chickenpox)
• Fever, headache, malaise, and pharyngitis with a 2-week
incubation
• Skin with widespread vesicular eruption
• Oral mucosa with short-lived vesicles that rupture forming shallow, defined ulcers
• Herpes zoster (shingles)
Unilateral, dermatomal, grouped vesicular eruption of skin and/or oral mucosa
• Vesicles may coalesce prior to ulceration and crusting.
• Lesions are painful.
• Prodromal symptoms along affected dermatome may occur.
• Pain, paresthesia, burning, tingling
• Postherpetic pain may be severe.

Diagnosis
• Clinical appearance and symptoms
• Cytologic smear with cytopathic effect present (multinucleated giant cells)
• Viral culture or PCR examination of blister fluid or scraping from base of erosion
• Serologic evaluation of VZV antibody
• Biopsy with direct fluorescent examination using fluoresceinlabeled VZV antibody

Differential Diagnosis
• Primary herpes simplex/acute herpetic gingivostomatitis
• Recurrent intraoral herpes simplex
• Pemphigus vulgaris
• Mucous membrane (cicatricial) pemphigoid

Treatment
• Symptomatic management in primary infection
• Antiviral drugs (especially acyclovir) in immunocompromised patients or patients with extensive disease
• Systemic corticosteroids may be used to help control/prevent postherpetic neuralgia.
• Pain control to prevent “CNS imprinting”

Prognosis
• Generally good
• Recurrences more likely in immunosuppressed patients




1 komentar:


  1. The worst time has passed”However, it is true that there are more improvements than before...because of the rising numbers of people living with HIV in the state of Nevada. How could they stigmatize all of them? Therefore everything becomes a little easier and we start to share everything... We also started to invite and visit each other in a community. You know, it is six years since I started taking antiretroviral drugs...Yet whatever problems I face, the worst time has passed
    When I was evicted from the family home by my mother, my father rented a small room for me. But my mother and brothers believed that having HIV was my own fault – and that I deserved to be punished...I also considered myself unworthy and without hope... But I have a child and eventually I convinced myself to live for my child’s sake.
    My mother knew nothing [about HIV]. She didn’t understand anything. Do you know why? She didn’t have [the chance] to go out of the house and communicate with society. However, my father does interact with the community. I know his friends are mature and dignified in africa america. So he has a better understanding than her.
    My father came call me on a sadfull day sitting on my couch about a friend of his from africa who introduce him to Dr Itua herbal cure in africa in which he advise we should purchase his herbal medicine to cure my hiv so we did and Dr Itua prescribed I should drink the herbal medicine for two weeks to cure although we were so curious about the whole thing ,I finished the herbal medicine like he advised then he talked to me to visit my nearest clinic for check up I did and now I'm totally cured from Hiv my father was my rock and I and my family are now happy together also Dr Itua has be helpful in my community ever since he cure my Hiv so why I'm leaving my story on here today is to reach out someone out here to hope on God and never give up no matter the situation you that you are facing especially through this pandemic seasons which has really taught us all on how we should be helpful to each other and cherish one another.
    Dr Itua cures the following diseases..... Herpes,Liver cancer,Throat cancerLeukemia. ,Alzheimer's disease,Chronic Diarrhea,Copd,Parkinson,Als,Adrenocortical carcinoma Infectious mononucleosis.
    Intestinal cancer,Uterine cancer,Fibroid,Bladder cancer,Hiv,Esophageal cancer,Gallbladder cancer,Kidney cancer,Hpv,Lung cancer,Melanoma,Mesothelioma,Multiple myeloma,Oral cancer,Sinus cancer,Hepatitis A,B/C,Skin cancer,Soft tissue sarcoma,Spinal cancer,Stomach cancer,Vaginal cancer,Vulvar cancer,
    Testicular cancer ,Thyroid Cancer.
    You can contact Dr Itua Herbal Center on E-Mail: drituaherbalcenter@gmail.com .www.drituaherbalcenter.com

    BalasHapus